The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dissecting tumor-immune dynamics and radiotherapy response in oligometastatic prostate cancer.
 
Sophia C. Kamran
Employment - Sanofi (I)
Honoraria - Medscape; Varian Medical Systems
 
Yukako Otani
No Relationships to Disclose
 
David Qi
No Relationships to Disclose
 
Isabella R Pompa
No Relationships to Disclose
 
Richard Dzeng
No Relationships to Disclose
 
Rea Pittie
No Relationships to Disclose
 
Ella Chung
No Relationships to Disclose
 
Keisuke Otani
No Relationships to Disclose
 
Jennifer Yon-Li Wo
Honoraria - PER
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Lynx Group
 
Anthony L. Zietman
No Relationships to Disclose
 
Patrick Reeves
No Relationships to Disclose
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - ervaxx; Genome Medical; Genomic Life; Manifold Bio; Microsoft; Monte Rosa Therapeutics; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Consulting or Advisory Role - ervaxx; Genome Medical; Genomic Life; Illumina; Janssen; Manifold Bio; Monte Rosa Therapeutics; Novartis; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent on clinical interpretation algorithms using cancer molecular data (Inst); Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Jason A. Efstathiou
Honoraria - IBA
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Blue Earth Diagnostics; Boston Scientific; Genentech; Gilead Sciences; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Pfizer; Progenics
 
David Tomoaki Miyamoto
Research Funding - Cardiff Oncology (Inst)